Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability.
Leoni G, D'Alise AM, Cotugno G, Langone F, Garzia I, De Lucia M, Fichera I, Vitale R, Bignone V, Tucci FG, Mori F, Leuzzi A, Di Matteo E, Troise F, Abbate A, Merone R, Ruzza V, Diodoro MG, Yadav M, Gordon-Alonso M, Vanhaver C, Panigada M, Soprana E, Siccardi A, Folgori A, Colloca S, van der Bruggen P, Nicosia A, Lahm A, Catanese MT, Scarselli E. Leoni G, et al. Among authors: van der bruggen p. Cancer Res. 2020 Sep 15;80(18):3972-3982. doi: 10.1158/0008-5472.CAN-20-1072. Epub 2020 Jul 20. Cancer Res. 2020. PMID: 32690723
Identification of tumour rejection antigens recognized by T lymphocytes.
Boon T, De Plaen E, Lurquin C, Van den Eynde B, van der Bruggen P, Traversari C, Amar-Costesec A, Van Pel A. Boon T, et al. Among authors: van pel a, van den eynde b, van der bruggen p. Cancer Surv. 1992;13:23-37. Cancer Surv. 1992. PMID: 1423324 Review.
A new LAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-A68 tumors.
Sun Z, Lethé B, Zhang Y, Russo V, Colau D, Stroobant V, Boon T, van der Bruggen P. Sun Z, et al. Among authors: van der bruggen p. Cancer Immunol Immunother. 2006 Jun;55(6):644-52. doi: 10.1007/s00262-005-0066-x. Epub 2005 Sep 27. Cancer Immunol Immunother. 2006. PMID: 16187088 Free PMC article.
A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice.
Demotte N, Wieërs G, Van Der Smissen P, Moser M, Schmidt C, Thielemans K, Squifflet JL, Weynand B, Carrasco J, Lurquin C, Courtoy PJ, van der Bruggen P. Demotte N, et al. Among authors: van der smissen p, van der bruggen p. Cancer Res. 2010 Oct 1;70(19):7476-88. doi: 10.1158/0008-5472.CAN-10-0761. Epub 2010 Aug 18. Cancer Res. 2010. PMID: 20719885 Free article.
Database of T cell-defined human tumor antigens: the 2013 update.
Vigneron N, Stroobant V, Van den Eynde BJ, van der Bruggen P. Vigneron N, et al. Among authors: van den eynde bj, van der bruggen p. Cancer Immun. 2013 Jul 15;13:15. Print 2013. Cancer Immun. 2013. PMID: 23882160 Free PMC article. Review.
141 results